Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atsena, Boehringer Ingelheim, GSK, Kalvista, Milestone.

Biopharmas raising money in public or private financings, including: Alopexx, Ascelia, Bicara, Biotech Consortia, Orsobio, Zenas.

New hires and promotions in the biopharma industry, including: Aavantgarde, Advantage, Apogee, Cassava, Cue, Diogenx, Eli Lilly, Latigo, Theras.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amneal, Moebius, Shilpa, Sun Pharmaceutical, Travere.

A quick look back at top stories.

The top 10 biopharma stock gainers and losers for the week.

These graphs compare the performance of the biotech stocks for all of 2024 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.

Biopharma money raised to-date and by month in 2023, including public, private and other financings.